Delivery Order SPE2DB20D3103-SPE2DB25FM2Y4
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,454.59 delivery order contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of July 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,479.48, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract is a firm fixed price delivery order with a completion date of February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP7JL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,468 Firm Fixed Price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,292.34, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract was awarded on January 15, 2025, and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,877.84 firm fixed-price delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA), a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $7,271.33 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen, through its extensive federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,818.51, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of February 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract...
This federal contract award, valued at $58,961.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical product, with a performance period ending on November 21, 2024. The contract is a Firm Fixed Price arrangement and does not include any set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,513.68 delivery order contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a rheumatoid arthritis medication, to support military healthcare programs. The contract has an ultimate completion date of November 26, 2024 and utilizes a firm fixed price pricing type. This award is associated with a...